Why does a shunt result in refractory hypoxemia

He was evaluated for an underlying hypercoagulable state but did not have Factor V Leiden mutation or antiphospholipid antibodies. Written informed consent was obtained from the patient.

Massive, or high-risk, PE occurs in the setting of persistent hypotension with systolic blood pressure less than 90 mmHg for 15 minutes or greater. Normotensive individuals with evidence of right-sided heart dysfunction, whether on imaging such as computed tomography or echocardiography, or by elevated cardiac biomarkers such as troponin or creatine kinase-myocardial band, are classified as having submassive, or intermediate-risk, PE.

Acute PE is often considered when hypoxemia develops. However, PE alone rarely causes hypoxemia to the degree seen in our patient, and it may be useful in such cases to perform an evaluation for an intracardiac shunt.

The shunt permits LV filling and near-normal cardiac output, thus preventing hypotension. However, hypoxemia ensues because of the intracardiac mixing of deoxygenated with oxygenated blood.

Individual cases, presented in either case reports or case series, were selected. Further relevant case reports were extracted from the bibliography of articles gathered from the search. In total, there were 9 articles with 12 individual cases reported of acute PE occurring in the setting of PFO and resulting in persistent hypoxemia Table 2.

No patients received catheter-directed thrombolysis. Among patients with submassive PE in the PEITHO Pulmonary Embolism Thrombolysis randomized controlled trial, systemic thrombolysis with tenecteplase resulted in significant improvement in the combined primary outcome of all-cause mortality or hemodynamic compromise within 7 days over the administration of unfractionated heparin alone 2.

However, there was no overall mortality benefit, and there were more patients with major extracranial hemorrhages 6. There were no instances of major bleeding in this study. Patients with a right-to-left heart shunt, such as a PFO, were excluded from the study population. Two recent meta-analyses, 16,17 both including PEITHO, found that systemic thrombolysis decreases overall mortality while increasing major bleeding for acute PEs of both high and intermediate risk.

The meta-analysis by Marti et al 16 found that day mortality was significantly decreased with systemic thrombolysis 2. However, day overall mortality was not significantly different when the analysis included only intermediate risk PE.

The revision of the American College of Chest Physicians guidelines for venous thromboembolism, 2 as well as the European Society of Cardiology guidelines for acute PE, 3 recommend systemic thrombolysis for acute massive PE a Grade 1B recommendation in the American College of Chest Physicians guidelines.

Both sets of guidelines recommend against routine systemic thrombolysis in individuals with PE but who do not have shock or hypotension, unless they have clinical deterioration Grade 1B recommendation. Although there are no comparative trials of catheter-directed vs systemic thrombolytics, 19 we pursued catheter-directed thrombolysis because of the possible lower risk of bleeding and our institutional experience with this procedure Grade 2C recommendation per American College of Chest Physicians guidelines.

Another negative consequence of PFO is the risk of paradoxical emboli resulting in strokes. Such patients may hypothetically be at increased risk of intracranial hemorrhage from hemorrhagic conversion of these paradoxical strokes after undergoing systemic or catheter-directed thrombolysis.

However, there was no between-group difference in the proportion of patients receiving systemic thrombolysis. Other management considerations in patients with PE besides thrombolytics or anticoagulation therapy include mechanical or medical support of RV failure and surgical embolectomy.

Pulmonary vasodilators may also be used to decrease pulmonary vascular resistance in situations of acute RV failure, such as acute PE. Inhaled nitric oxide has a rapid onset and short half-life, making it easily titratable.

Venovenous ECMO was used in 1 case in our literature review as a bridge to surgery; that patient had concurrent cardiac failure and was reliant on a biventricular assist device. The management of acute submassive PE is undertaken on an individualized basis, given the spectrum of clinical presentations of such cases.

The use of systemic thrombolysis should be weighed against the risk of severe bleeding. The outcomes of catheter-directed interventions compared with systemic thrombolysis are yet unknown. In acute PE with refractory hypoxemia in which an intracardiac shunt is the cause, there is even less evidence to guide decision making, because many of the large trials exclude patients with PFO or do not specifically identify these patients.

When deciding between systemic or catheter-directed thrombolysis or anticoagulation therapy alone, the clinician should consider individual patient factors and the potential increased risk of intracranial hemorrhage because of a PFO. Finally, if there is a failure of systemic thrombolysis to decrease pulmonary arterial pressure and the intracardiac shunt, then bridging therapies such as ECMO or surgical embolectomy must be considered.

Respir Care ; 48 1 : 58 — Portohepatic vascular pathology and liver disease: diagnosis and monitoring. OpenUrl PubMed. Atasoy C , Akyar S. Multidetector CT: contributions in liver imaging. Acta Radiol ; 52 5 : — Contrast echocardiography in detection of portopulmonary venous anastomosis. Schoenmackers J , Vieten H. Fortschr Geb Rontgenstr ; 79 4 : - Article in German. Porto-pulmonary venous anastomosis in portal hypertension demonstrated by percutaneous transhepatic cine-portography.

Radiology ; 3 : — Calabresi P , Abelmann WH. Porto-caval and porto-pulmonary anastomoses in Laennec's cirrhosis and in heart failure. J Clin Invest ; 36 8 : — Tcm MAA total-body imaging to detect intrapulmonary right-to-left shunts and to evaluate the therapeutic effect in pulmonary arteriovenous shunts. Clin Nucl Med ; 21 3 : — Protocol for optimal detection and exclusion of a patent foramen ovale using transthoracic echocardiography with agitated saline microbubbles.

Echocardiography ; 23 7 : — Value of contrast echocardiography for the diagnosis of hepatopulmonary syndrome. Eur J Echocardiogr ; 8 5 : — Computed tomography findings of spontaneous porto-pulmonary shunts in 3 patients with portal hypertension.

FIO2 as low as is allowed to maintain adequate oxygen saturation to minimize possible oxygen toxicity. PEEP Ventilator settings Mechanical ventilation can be Noninvasive, involving various types of face masks Invasive, involving endotracheal intubation Selection and use of appropriate techniques require an understanding However, compared with treatment of cardiogenic pulmonary edema, higher levels of support for a longer duration are often required, and EPAP of 8 to 12 cm H2O is often necessary to maintain adequate oxygenation.

Also, NIPPV-treated patients who subsequently need intubation have generally progressed to a more advanced condition than if they had been intubated earlier; thus, critical desaturation is possible at the time of intubation. Conventional mechanical ventilation in ARDS previously focused on normalizing arterial blood gas values.

It is clear that ventilating with lower tidal volumes reduces mortality. If pH drops below 7. Sedation is preferred to neuromuscular blockade because blockade still requires sedation and may cause residual weakness. The optimal level of PEEP and the way to identify it have been debated. Routine use of recruitment maneuvers eg, titration of PEEP to maximal pressure of 35 to 40 cm H2O and held for 1 minute followed by decremental PEEP titration was found to be associated with an increased day mortality 1 Treatment references Acute hypoxemic respiratory failure is severe arterial hypoxemia that is refractory to supplemental oxygen.

Therefore, many clinicians simply use the least amount of PEEP that results in an adequate arterial oxygen saturation on a nontoxic FIO2. In these cases, close attention must be paid to other means of optimizing oxygen delivery and minimizing oxygen consumption. The best indicator of alveolar overdistention is measurement of a plateau pressure through an end-inspiratory hold maneuver Respiratory Mechanics Mechanical ventilation can be Noninvasive, involving various types of face masks Invasive, involving endotracheal intubation Selection and use of appropriate techniques require an understanding The target plateau pressure is 30 cm H2O.

If the plateau pressure exceeds this value and there is no problem with the chest wall that could be contributing eg, ascites Ascites Ascites is free fluid in the peritoneal cavity. The most common cause is portal hypertension. Symptoms usually result from abdominal distention.

Diagnosis is based on physical examination and They have multiple causes and usually are classified as transudates or exudates. Detection is by physical examination and Many chest injuries cause death during the first minutes or hours after trauma; they can frequently be treated at the bedside Some investigators believe pressure control ventilation protects the lungs better, but supportive data are lacking, and it is the peak pressure rather than the plateau pressure that is being controlled.

With pressure control ventilation, because the tidal volume will vary as the patient's lung compliance evolves, it is necessary to continually monitor the tidal volume and adjust the inspiratory pressure to ensure that the patient is not receiving too high or too low a tidal volume. Then, PEEP is decreased in 2. Ideal body weight IBW rather than actual body weight is used to determine the appropriate tidal volume for patients with lung disease receiving mechanical ventilation:.

Prone positioning Patient positioning Mechanical ventilation can be Noninvasive, involving various types of face masks Invasive, involving endotracheal intubation Selection and use of appropriate techniques require an understanding One study suggests this positioning substantially improves survival 2, 3 Treatment references Acute hypoxemic respiratory failure is severe arterial hypoxemia that is refractory to supplemental oxygen.

Interestingly, the mortality benefit from prone positioning is not related to the degree of hypoxemia or the extent of gas exchange abnormality but possibly to mitigating ventilator-induced lung injury VILI. Optimal fluid management in patients with ARDS balances the requirement for an adequate circulating volume to preserve end-organ perfusion with the goal of lowering preload and thereby limiting transudation of fluid in the lungs.

A large multicenter trial has shown that a conservative approach to fluid management, in which less fluid is given, shortens the duration of mechanical ventilation and length of stay in the intensive care unit when compared with a more liberal strategy. However, there was no difference in survival between the 2 approaches, and use of a pulmonary artery catheter also did not improve outcome 4 Treatment references Acute hypoxemic respiratory failure is severe arterial hypoxemia that is refractory to supplemental oxygen.

Patients not in shock Shock Shock is a state of organ hypoperfusion with resultant cellular dysfunction and death. Mechanisms may involve decreased circulating volume, decreased cardiac output, and vasodilation, sometimes A definitive pharmacologic treatment for ARDS that reduces morbidity and mortality remains elusive. Inhaled nitric oxide, surfactant replacement, activated protein C drotrecogin alfa , and many other agents directed at modulating the inflammatory response have been studied and found not to reduce morbidity or mortality.

Some small studies suggest that systemic corticosteroids may be beneficial in late-stage fibroproliferative ARDS, but a larger, prospective, randomized trial found no reduction in mortality. Corticosteroids may be deleterious when given early in the course of the condition. JAMA 14 —, N Engl J Med 23 —, Chest —, Epub Jul 8.

N Engl J Med 24 —, From developing new therapies that treat and prevent disease to helping people in need, we are committed to improving health and well-being around the world.

The Manual was first published in as a service to the community. Learn more about our commitment to Global Medical Knowledge. The most common clinical variables that specifically affect these various levels is shown: Level C is most commonly affected by changes in F I O 2 inspired oxygen fraction , Level A is specifically affected by changes in the physiological shunt Q SP , Level V is specifically affected by both the total cardiac output Q T and the rate of oxygen consumption VO 2.

The numerator of the shunt equation is represented by differences in C c O 2 and C a O 2. The denominator of the equation is represented by the differences in C c O 2 and C v O 2.

Changes of unequal magnitude among these three levels will change the ratio, which is equivalent to changes in the physiologic shunt calculation. If a patient develops fulminant right-, middle- and lower-lobe consolidation, the arterial and pulmonary artery blood gas measurements would reveal a clinical picture as reflected in Fig.

The arterial oxygen tension and content are significantly decreased due to a large intrapulmonary shunt. If the cardiac output remains unchanged and the arterial-mixed venous oxygen difference does not change, then the C v O 2 must also decrease. Because of the change of unequal magnitude, the physiologic shunt will greatly increase secondary to hypoxemia. Schematic representation of changes in blood oxygen levels under various conditions.

The purpose of this illustration is to conceptualize the difference between physiologic shunting and the hypoxemic effect of physiologic shunting. I, II, and III illustrate changes in a normal individual who contracts pneumonitis that causes a significant increase in intrapulmonary shunting without any compensatory physiologic change. The status from normal to acute pneumonia shows: no change in Level C because ventilation and F I O 2 are unchanged, a specific drop in Level A due to increased shunting created by the pneumonia, and a drop in Level V because the AV content difference is unchanged cardiac output and oxygen consumption unchanged.

Since Diff N has increased to a greater degree than Diff D, the calculated shunt increases. Level C remains unchanged since neither ventilation nor F I O 2 has been altered. The AV content difference has narrowed because the cardiac output has increased, while oxygen consumption remains unchanged. The increase in Level V results in a new dynamic equilibrium in which Level A is also increased.

Note that the relationship between Diff N and Diff D is only slightly altered. Thus, Level A and therefore the P a O 2 has increased with little change in the calculated shunt. In this instance, the compensation for hypoxemia is cardiovascular; the intrapulmonary shunt has not changed. Level C increases, while AV content difference remains unchanged cardiac output and oxygen consumption unchanged. A new dynamic equilibrium results in Level A and therefore the P a O 2 increasing.

The relationship between Diff N and Diff D is only slightly altered. Level A and therefore P a O 2 has increased with little change in the calculated shunt. In this instance, compensation for hypoxemia is via oxygen therapy; the intrapulmonary shunt is essentially unchanged.

Severe hypoxemia will usually lead to an increase in cardiac output. This results in a decrease in the arterial-venous oxygen content difference as reflected by an increase in C v O 2. The arterial PO 2 improves greatly, without a significant change in physiologic shunt secondary, due to an improved cardiac output. If the assumption is made that supplemental oxygen is administered to this patient while the cardiac output remains unchanged, C c O 2 is increased secondary to an increased alveolar PO 2.

Since the physiologic shunt remains the same and the arterial-venous oxygen content difference remains the same, a new equilibrium results in C a O 2 and C v O 2 increasing. Finally, the circumstances are changed to depict a patient with oxygen therapy and an increase in cardiac output.

The intrapulmonary shunt can be measured only when both arterial and pulmonary arterial blood samples are available and the F I O 2 is constant. Catheters inserted into the central venous circulation that lie just above the superior vena cava-right atrial junction are largely inadequate for shunt determinations because blood drawn from this position will not contain the significantly desaturated blood from the coronary sinus or inferior vena cava.

Blood samples taken from the right atrium exhibit significant oxygen content variation because of channeling of blood flow and movement of the catheter tip. Catheter tips in the right ventricle may cause ventricular ectopy and yield variable oxygen content samples. Mixed venous samples are obtained from a pulmonary artery catheter.

If at all possible, the patient should not be stimulated or disturbed for several minutes before sampling. Care should be taken to avoid airway suctioning and other procedures during this time period.